<html>
<head>PUBMED IDs for SEC14L1</head>
<body bgcolor='#C5F0F2'><h1>SEC14L1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17092608/'>SEC14-like protein 1 interacts with cholinergic transporters.</a> November 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20510747/'>T cell-based functional cDNA library screening identified SEC14-like 1a carboxy-terminal domain as a negative regulator of human immunodeficiency virus replication.</a> August 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/23083832/'>A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.</a> March 22  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23676757/'>Identification of biomarkers for Mycobacterium tuberculosis infection and disease in BCG-vaccinated young children in Southern India.</a> March 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23843640/'>Negative regulation of RIG-I-mediated innate antiviral signaling by SEC14L1.</a> November 7  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24739497/'>Concordant or discordant results by the tuberculin skin test and the quantiFERON-TB test in children reflect immune biomarker profiles.</a> April 11  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25701228/'>Saccharomyces cerevisiae-like 1 overexpression is frequent in prostate cancer and has markedly different effects in Ets-related gene fusion-positive and fusion-negative cancers.</a> June 9  2015<br></body></html>
